Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CADET

Financiado

Cerrado

Post transcriptional Control of the Aire Driven expression of self antigens in t...

Post transcriptional Control of the Aire Driven expression of self antigens in the Thymus Immune tolerance is key to the maintenance of the integrity of organisms against foreign invaders with respect to self-constituents. Deregulation of this mechanism promotes the occurrence of life-threatening autoimmune diseases th... ver más

31/07/2015

INSERM

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2015-07-31 No tenemos la información de la convocatoria

0% 100% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

INSERM

0.00€ | Lider

Proyectos interesantes

SELF-TOLERANCE

Medical Technol...

Applied Physics

2M€ Cerrado

AIRE-TOP2A

Medical Technol...

Immunology

100K€ Cerrado

RTI2018-100008-A-I00

Medical Technol...

Immunology

194K€ Cerrado

ThymusTolerance

Medical Technol...

Immunology

2M€ Cerrado

BES-2015-074528

Medical Technol...

Immunology

93K€ Cerrado

SAF2011-23639

Medical Technol...

Immunology

230K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Immune tolerance is key to the maintenance of the integrity of organisms against foreign invaders with respect to self-constituents. Deregulation of this mechanism promotes the occurrence of life-threatening autoimmune diseases that affect 5-10% of the general population. Previously, the transcriptional activator (Aire) was shown to play a key role in immune tolerance. Indeed, Aire induces medullary epithelial cells in the thymus (MECs) to synthesize and present a large repertoire of peripheral self-antigens (a self-shadow), leading to the clonal deletion of self-reactive maturing T cells and thereby protecting against autoimmune manifestations. In addition to activating transcription, preliminary results indicate that Aire induces 3’UTR shortening of its sensitive transcripts in MECs, and that these cells show an accumulation of miRNAs. The goal of our project is to describe a post-transcriptional control of the Aire-driven expression in the thymus that leads to higher levels of Aire-dependent self-antigens, and to identify key molecular players involved in this mechanism. We first propose to confirm that Aire-induced transcripts have shorter 3’UTR ends by mRNA high-throughput sequencing in primary MECs, and that these transcripts escape a miRNA-mediated post-transcriptional repression in a MEC cell line. We will also seek factors involved in Aire-triggered 3’UTR shortening by performing a lentivirus-based RNAi screen of a set of RNA-binding proteins in an in vitro model that we will set up. Finally we will validate some of the best candidates in vivo by generating knock-down mice using a high-speed lentigenic approach based on oocytes infection with lentiviruses delivering targeting short-hairpin RNAs. Altogether the expected results should uncover an important layer of control of self-antigen expression in the thymus mediating immune tolerance, and provide new potential targets for therapeutic intervention in autoimmune diseases.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores